SCHEMBL26328449

SCHEMBL26328449

Cc1ccc(-c2ccc(-c3cc4cccc5ccc6cccc3c6c54)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.46
MAOA P21397 2/20 0.46
ERBB2 P04626 1/20 0.46
FYN P06241 1/20 0.46
ACHE P22303 1/20 0.46
AHR P35869 1/20 0.46
ALDH1A1 P00352 5/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP3A4 P08684 2/20 0.44
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ADORA3 P0DMS8 3/20 0.42
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
GPR84 Q9NQS5 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27717676 0.86 CYP1A2 (0.53) CYP1A2MAOAERBB2FYNACHE
SCHEMBL21960023 0.86 ALDH1A1 (0.52) CYP1A2MAOAERBB2FYNACHE
SCHEMBL27703274 0.84 CYP1A2 (0.47) CYP1A2MAOAERBB2FYNACHE
SCHEMBL2291863 0.84 ALDH1A1 (0.53) CYP1A2MAOAERBB2FYNACHE
Ammonia Solution, Strong SCHEMBL27726554 0.82 ALDH1A1 (0.52) CYP1A2MAOAERBB2FYNACHE
SCHEMBL27726552 0.82 MEN1 (0.45) CYP1A2MAOAERBB2FYNACHE
SCHEMBL14962025 0.82 MEN1 (0.42) CYP1A2MAOAERBB2FYNACHE
Ammonia Solution, Strong SCHEMBL27752672 0.82 ALDH1A1 (0.44) CYP1A2MAOAERBB2FYNACHE
SCHEMBL11654321 0.82 CYP1A2 (0.57) CYP1A2MAOAERBB2FYNACHE
SCHEMBL28362148 0.82 GRM2 (0.41) CYP1A2MAOAALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes SONY CORPORATION (JP) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes JUP, L1CAM, EPCAM CYP1A2 1899/4885MAOA 1681/4885ERBB2 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.